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Sir
We read with great interest the results of a randomized trial inves-
tigating the omission of radiation as a component of breast
conservation therapy for a favourable subset of women with stage
I breast cancer (Holli et al, 2001). The data demonstrated that the
locoregional recurrence was reduced in the patients randomized to
radiotherapy (6.2% (radiation) vs 14.1% (no radiation) (P=0.029)),
but there was no difference in rates of distant metastases or breast
cancer deaths. In addition, because the patients who recurred after
lumpectomy alone were most often treated with a second lumpect-
omy and radiation, the ﬁnal rates of breast conservation were
equivalent between the two arms.
A number of points should be considered when interpreting the
data of this trial, particularly because these data have the potential
of leading to a further decline in the use of radiation following
breast conservation surgery. The ﬁrst point is that the population
studied represents a very small subset of women with early stage
breast cancer. Despite the study’s highly selective eligibility criteria,
radiation clearly reduced the risk of local-regional recurrences.
These data are consistent with those from previously published
prospective trials that also studied highly selected favourable
patients and found increased rates of breast recurrences when
radiation was omitted (Veronesi et al, 1993; Schnitt et al, 1996;
Liljegren et al, 1997; Wollmark et al, 2000).
The new twist of this trial is the assertion that breast preserva-
tion rates and survival may be equivalent without initial radiation
because of the availability of re-excision and radiation as a salvage
therapy for those initially treated with surgery alone. In the Holli et
al (2001) trial, rates of breast preservation does not appear to have
been a predetermined endpoint of the study. The choice of salvage
therapy apparently was not determined by the protocol and there-
fore was likely affected by a number of biases. In addition, the
length of follow-up after salvage treatment was not provided and
the long-term efﬁcacy of re-excision with or without radiation
has not been established. Therefore, we feel that this endpoint
should not have been reported.
The goals of all breast cancer therapies are to minimize the risk
of breast cancer death and provide the patient with the best quality
of life. The authors acknowledge that developing a potentially
avoidable local recurrence, even if it is curable with salvage therapy,
has a signiﬁcant negative impact on the quality of life of a patient.
A second factor that impacts the quality of life of patients is the
ﬁnal aesthetic outcome of the treatment. The authors stated that
radiation can have a negative impact on aesthetics and in their
study was avoided in 87.5% of those randomized to the no radia-
tion arm. Aesthetic results are also highly dependent of the extent
of surgery. To be eligible for this trial a 1-cm negative microscopic
margin was needed. This degree of normal tissue margins requires
a considerable volume of breast to be resected and is not necessary
for patients receiving radiation. Furthermore, for patients under-
going additional conservative surgery for recurrence, the aesthetic
results are likely to be signiﬁcantly compromised. No reports of
aesthetics outcomes are reported for this study.
Finally, a critical question for patients and practitioners to
consider is whether increased rates of local recurrences predispose
patients to higher rates of distant metastases. This study suggested
rates were equivalent, but because of the small number of patients
in the study, there were only nine total metastatic events. Further-
more, the authors reported the distribution of these events between
the two arms differently in the text of their results section
compared to the same data presented in their Figure 2. A large
number of patients with a long follow-up period are required to
properly study the relationship between locoregional recurrence
and distant failure. A recently published meta-analysis that evalu-
ated the outcome of 2091 women treated on breast conservation
randomized trials reported that those receiving radiation had a
14% lower relative risk of dying from breast cancer than those
patients randomized to not receive radiation (Early Breast Cancer
Trialists’ Collaborative Group, 2000). This beneﬁt suggests that
some local-regional recurrences are associated with new distant
metastases and this relationship should be considered when decid-
ing the optimal manner in which early stage breast cancer should
be treated.
It is our opinion that sufﬁcient randomized data is available to
recommend radiation therapy as a standard after lumpectomy for
all women with invasive breast cancers. We feel that omission of
radiation should not be offered outside the context of a clinical study.
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Sir
Buchholz and Singletary raise the following issues in their
commentary to our study (Holli et al, 2001):
. the breast preservation rate should not have been reported as an
endpoint as it was not predetermined by the protocol and,
therefore, it is subject to bias
. no aesthetic outcomes were reported
. loco-regional recurrences are likely to be associated with distant
metastases and an increased risk of death. Hence, longer follow-
up after salvage therapy is needed.
The mastectomy rate following conservative surgery depends on a
number of factors, such as the relative size of the recurrent tumour
with respect to the breast size, location of the tumour, availability of
breast reconstruction, skill and experience of the surgeon, and patient
preference. Therefore, we preferred not to give strict guidelines in the
studyprotocolforthetypeofbreastsurgeryusedfollowingrecurrence,
nor did weselect the breastpreservation rate as a study endpoint. Had
the breast preservation rate been predetermined as an endpoint, the
attitudes of the clinicians might have inﬂuenced the choice of the type
of surgery more than in the present design, where no emphasis was
given on the issue prospectively. Hence, it is possible that our study
design may have been even less biased than after predetermining the
breast preservation rate as an endpoint.
Cosmetic outcome was not reported in our article, but we did
study it by asking the subjective opinions of the patient and the
physician. The results on the cosmetic outcome are shown in Table
1. We considered the cosmetic result poor only when both the
patient and physician regarded the result as such. There was no
difference between the study arms in the cosmetic outcome 6
months following surgery. The cosmetic result following removal
of the recurrent tumour was not assessed formally.
It is generally accepted that loco-regional recurrences are asso-
ciated with an increased risk for distant metastases and death.
However, the data is scanty in the subset of very low risk patients.
We intentionally selected a very low risk subgroup for the study,
and when looking at the 6-year survival rates it is evident that
Table 1 Relative harms and merits associated with breast radiation in
low risk breast cancer patients treated with conservative surgery
Radiation
(n=80) No radiation (n=72)
Relative
End point n (%) n (%) harm ratio
Poor cosmesis 11 14 9 13 1.1
(6 months after surgery)
Recurrence 6 8 13 18 0.4
Distant metastasis 7 9 2 3 3.1
Recurrence leading to 4 5 4 6 0.9
mastectomy
Death 2 3 2 3 0.9
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we emphasized in our article, the risk for local relapse is quite high
(18% in our study) even in this very low risk group when radio-
therapy is omitted. We fully agree with Buchholz and Singletary
that a long follow-up time is needed in this low risk group, because
the tumours, in particular, are likely to have a slow cell prolifera-
tion rate, and both local and distant metastases may need a long
time to appear. We plan to perform a new analysis after 10-year
follow-up of the patient cohort. Seven patients in the post-opera-
tive radiation group and two in the non-radiation group have
recurred distally, and we apologize for the incorrect numbers in
Figure 2 of our previous paper (Holli et al, 2001).
The main message from the study is that radiotherapy decreases
the risk for local relapse even in low risk patients after conservative
breast surgery. However, it remains to be conﬁrmed that radiother-
apy decreases the rate of mastectomies in this carefully selected and
closely followed subgroup of patients, where the option for reexci-
sion and radiotherapy may still be available when radiotherapy has
not been given primarily. In general our recommendation is to give
radiotherapy to all patients with invasive breast cancer after conser-
vative surgery to avoid local relapses, and we agree that omission of
radiotherapy should be done only in the context of a clinical study.
REFERENCES
Holli K, Saaristo R, Isola J, Joensuu H, Hakama M (2001) Lumpectomy with
or without postoperative radiotherapy for breast cancer with favourable
prognostic features: results of a randomized study. Br J Cancer 84: 164–
169
Letters to the Editor
311
ã 2002 The Cancer Research Campaign British Journal of Cancer (2002) 86(2), 309–311